Friday, May 15

11:30 a.m.	Registration Desk Opens - Poster Set Up and Networking Available
12:00 p.m.	Breakout Sessions (60-minute blocks in small groups- Limited to 20 seats per session) VC Pitch 101 – Niall O’Donnell, PhD, MA, MBA - Managing Director, RiverVest Behind the Protocol: Key Operational Insights from Clinical Trial Execution – Doreen Miao, Vice President, Marketing & Strategic Development, THORASYS Talking to Industry 101 – Maria Artunduaga, MD, MPH, MTM, Founder and CEO, Samay Health Recruiting Patients for Trials (Patient Advocacy) – Teresa Barnes, Chief Executive Warrior, PF Warriors Logistics in Early Decision Making & Operations – Shane Krauss, Director of Strategy, Strados Labs, Inc. Pre-Clinical to Phase 1 Transition – Jason Kirkness, PhD, ATSF, SMSBiotech How Imaging AI is Changing the Landscape of Pharma Clinical Trials - Todd Johnson, Chief Technology Officer and Josh Schirm, Senior Director, Clinical Development from VidaLung AI
4:00 p.m.	Networking Session
5:00 p.m.	Networking Reception – Posters Available
6:00 p.m.	Co-Chairs’ Welcoming Comments Craig Conoscenti, MD, ATSF, Senior Vice President, Avalyn Pharma, Inc. Niall O’Donnell, PhD, MA, MBA – Managing Director, RiverVest
6:10 p.m.	Visionary Sponsor Address- Presented by Boehringer Ingelheim Pharmaceuticals, Inc.
6:40 p.m.	Opening Showcase – Welcome to Innovation Moderator TBD
7:10 p.m.	Networking Reception and Poster Viewing
9:00 p.m.	Adjourn

Saturday, May 16

7:15 a.m.	Continental Breakfast – Posters Available
8:00 a.m.	Welcome from the ATS President Raed A. Dweik, MD, MBA, ATSF
8:10 a.m.	Co-Chair Address: State of Innovation and Investment Craig Conoscenti, MD, ATSF – Senior Vice President, Avalyn Pharma, Inc. Niall O’Donnell, PhD, MA, MBA – Managing Director, RiverVest
8:30 a.m.	Showcase One: TBD
9:00 a.m.	Panel: Investor Discussion Moderator: TBD
9:45 a.m.	Networking Break – Posters Available
10:15 a.m.	Showcase Two: TBD
10:45 a.m.	Smarter Signals: How Innovative Endpoints Are Changing the Drug Development Pathway Moderator: Doreen Miao, Vice President, Marketing & Strategic Development, THORASYS Adam LaPrad, PhD, Chief Technology Officer, ZephyRX Bina Cho, Medical Lead, Sanofi Glenn Crater, MD, Chief Medical Officer, Innospera Pharma Jan De Backer, PhD, Chief Executive Officer, Fluidda
11:30 a.m.	Showcase Three: TBD
12:00 p.m.	Lunch – Posters Available
1:00 p.m.	Panel: Business Development
1:45 p.m.	Showcase Four: TBD
2:30 p.m.	Networking Break – Posters Available
3:00 p.m.	Showcase Five: TBD
3:30 p.m.	RIS Featured Success Story
3:45 p.m.	Showcase Six: TBD
4:30 p.m.	Closing Remarks and Sponsor Recognition Craig Conoscenti, MD, ATSF – Senior Vice President, Avalyn Pharma, Inc. Niall O’Donnell, PhD, MA, MBA – Managing Director, RiverVest
4:45 p.m.	Networking Reception – Posters Available
6:00 p.m.	Adjourn